2. Search Result
Search Result
Results for "

AZD-9291-d<sub>6</sub>

" in MCE Product Catalog:
Targets Recommended:
Cat. No. Product Name Target Research Areas
  • HY-15772S
    Osimertinib-d6

    AZD-9291-d<sub>6sub>; Mereletinib-d<sub>6sub>

    		 EGFR Cancer
    Osimertinib-d6 is a deuterium labeled osimertinib. Osimertinib is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].